5000 Participants Needed

Advanced CT Imaging Techniques for Coronary Heart Disease

Recruiting at 1 trial location
MC
MY
Overseen ByMarcus Y Chen, M.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

Title: Evaluating New Radiation Techniques for Cardiovascular ImagingBackground:- Imaging studies such as computed tomography (CT) scans involve the use of radiation to create the pictures. Heart and blood vessel CT scans can cause high radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose. Researchers want to see how effective these new methods are in producing accurate CT scans.Objectives:- To study new ways of taking pictures of the heart or blood vessels using computed tomography.Eligibility:- Adults at least 18 years of age who will be having imaging studies to help detect heart or blood vessel problems.Design:* Participants will be screened with a physical exam and medical history. Blood samples will be taken to check kidney function.* Participants will have a CT scan of the heart and blood vessels. A contrast agent may be used to improve the quality of the images. The scanning session may last up to 2 hours.* Timing of and the need for follow up contact will depend on results from the initial scan and may be repeated to assess for late events. Telephone, office contact, or other follow-up of subjects may be done after CCTA to evaluate if the subject had subsequent cardiovascular testing. Further follow up will be based on reported test results.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

Is the Toshiba Aquilion ONE CT scanner safe for use in humans?

Research shows that advanced CT scanners, like the Toshiba Aquilion ONE, are designed to reduce radiation exposure, which is a key safety concern. Studies have focused on optimizing radiation doses to ensure patient safety while maintaining image quality.12345

How does the treatment in the clinical trial 'Advanced CT Imaging Techniques for Coronary Heart Disease' differ from other treatments for this condition?

This treatment uses advanced CT imaging techniques, such as multislice computed tomography (MSCT) and coronary computed tomography angiography (CCTA), to noninvasively assess coronary heart disease with high accuracy. It offers unique benefits like detailed evaluation of coronary artery stenoses, bypass patency, and myocardial function, while also incorporating dose-reduction strategies to minimize radiation exposure.678910

What data supports the effectiveness of the treatment The Toshiba Aquilion ONE CT system, Toshiba Aquilion ONE CT scanner for coronary heart disease?

Research shows that advanced CT imaging techniques, like those used in the Toshiba Aquilion ONE CT system, have improved image quality and reduced radiation exposure, making them effective for diagnosing coronary artery disease, especially in challenging cases.56101112

Who Is on the Research Team?

MY

Marcus Y Chen, M.D.

Principal Investigator

National Heart, Lung, and Blood Institute (NHLBI)

Are You a Good Fit for This Trial?

This trial is for adults over 18 who need a coronary CT angiography exam to check their heart or blood vessels. They must understand and sign consent, be able to follow up, and have working kidneys if using contrast. Pregnant individuals or those with severe kidney issues can't join.

Inclusion Criteria

Able and willing to provide follow-up information
I need a heart scan to check my arteries.
Able to understand and willing to sign the Informed Consent Form

Exclusion Criteria

I have severe kidney issues with a low filtration rate.
Screen Failures: Subjects who are screen failures can be re-enrolled once they meet eligibility criteria. Rescreened participants will be assigned the same participant number as for the initial screening.
Pregnancy

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Imaging

Participants will have a CT scan of the heart and blood vessels. A contrast agent may be used to improve the quality of the images.

1 day
1 visit (in-person)

Follow-up

Timing of and the need for follow-up contact will depend on results from the initial scan and may be repeated to assess for late events. Telephone, office contact, or other follow-up of subjects may be done after CCTA to evaluate if the subject had subsequent cardiovascular testing.

Ongoing

What Are the Treatments Tested in This Trial?

Interventions

  • The Toshiba Aquilion ONE CT system
Trial Overview Researchers are testing new low-radiation techniques in the Toshiba Aquilion ONE CT system for imaging the heart and blood vessels. Participants will undergo a detailed scan session that could use a contrast agent and will be followed up after 90 days, then yearly for five years.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

National Heart, Lung, and Blood Institute (NHLBI)

Lead Sponsor

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

The Angio-CT system was used in 1108 procedures, with 10% involving both CT and fluoroscopy, showing significant efficiency in performing non-complex bundled procedures in a single encounter.
Non-complex cases, such as pleural catheter placements, demonstrated a substantial reduction in room time (TRoom) and total encounter time (TEncounter), indicating that the Angio-CT system can streamline certain medical interventions effectively.
Hybrid CT-angiography (Angio-CT) for combined CT and fluoroscopic procedures in interventional radiology enhances utilization.Kwak, DH., Ahmed, O., Habib, H., et al.[2023]
In a study of 236 patients comparing two whole-heart coronary CT scanners, the GE Revolution CT scanner demonstrated more uniform contrast enhancement and lower image noise compared to the Toshiba Aquilion ONE Vision scanner, indicating better image quality.
The GE scanner also had a larger z-axis coverage and significantly lower radiation exposure (1.50 mSv) compared to the Toshiba scanner (1.9 mSv), making it a safer option for patients undergoing coronary computed tomographic angiography.
Comparison of Whole Heart Computed Tomography Scanners for Image Quality Lower Radiation Dosing in Coronary Computed Tomography Angiography: The CONVERGE Registry.Patel, N., Li, D., Nakanishi, R., et al.[2020]
Recent advancements in cardiac computed tomography (CT) and coronary CT angiography have significantly reduced radiation exposure while enhancing image quality, particularly for patients with high heart rates or severe calcification.
Key innovations include the development of area detectors, dual-source CT technology, and iterative reconstruction algorithms, which have collectively improved the safety and efficacy of cardiac imaging procedures.
Technical advances in cardiac CT.Achenbach, S., Kondo, T.[2012]

Citations

Hybrid CT-angiography (Angio-CT) for combined CT and fluoroscopic procedures in interventional radiology enhances utilization. [2023]
Comparison of Whole Heart Computed Tomography Scanners for Image Quality Lower Radiation Dosing in Coronary Computed Tomography Angiography: The CONVERGE Registry. [2020]
Technical advances in cardiac CT. [2012]
Introduction to coronary imaging with 64-slice computed tomography. [2016]
[Cardiac CT: new applications]. [2016]
Submillisievert median radiation dose for coronary angiography with a second-generation 320-detector row CT scanner in 107 consecutive patients. [2021]
A Preliminary Study of Computed Tomography Coronary Angiography Within a Single Cardiac Cycle in Patients With Atrial Fibrillation Using 256-Row Detector Computed Tomography. [2018]
Radiation exposure and projected risks with multidetector-row computed tomography scanning: clinical strategies and technologic developments for dose reduction. [2019]
Adverse events with universal use of iodixanol for CT: comparison with iohexol. [2016]
10.United Statespubmed.ncbi.nlm.nih.gov
Applications of multislice computed tomography in coronary artery disease. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Cardiac computed tomography technology and dose-reduction strategies. [2016]
12.United Statespubmed.ncbi.nlm.nih.gov
Current concepts in multi-detector row CT evaluation of the coronary arteries: principles, techniques, and anatomy. [2016]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity